Joincare Pharmaceutical Group Industry Co.,Ltd.

SWX:JCARE Stock Report

Market Cap: US$2.9b

Joincare Pharmaceutical Group IndustryLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Xiong Yu

Chief executive officer

CN¥3.6m

Total compensation

CEO salary percentage72.2%
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

CEO Compensation Analysis

How has Xiong Yu's remuneration changed compared to Joincare Pharmaceutical Group IndustryLtd's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CN¥1b

Jun 30 2024n/an/a

CN¥1b

Mar 31 2024n/an/a

CN¥1b

Dec 31 2023CN¥4mCN¥3m

CN¥1b

Sep 30 2023n/an/a

CN¥1b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥2b

Dec 31 2022CN¥4mCN¥3m

CN¥2b

Sep 30 2022n/an/a

CN¥1b

Jun 30 2022n/an/a

CN¥1b

Mar 31 2022n/an/a

CN¥1b

Dec 31 2021CN¥3mCN¥2m

CN¥1b

Compensation vs Market: Xiong's total compensation ($USD493.42K) is below average for companies of similar size in the Swiss market ($USD1.46M).

Compensation vs Earnings: Xiong's compensation has been consistent with company performance over the past year.


CEO

Xiong Yu (63 yo)

no data

Tenure

CN¥3,600,000

Compensation

Mr. Xiong Yu serves as Sichuan Biokin Pharmaceutical Co.,Ltd. since September 17, 2019. He served as Non-Executive Director of Livzon Pharmaceutical Group Inc. since June 30, 2020 until October 14, 2024.H...


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:31
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Joincare Pharmaceutical Group Industry Co.,Ltd. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
Ling Bo TuChina Minzu Securities
Shitong HanCitic Securities Co., Ltd.